Medtronic partnered with BioIntelliSense to acquire the BioButton multi-parameter wearable for continuous, connected monitoring to provide general care patients with access to a medical-grade gadget that continuously measures their vital signs and enables proactive clinical intervention and supporting workflow automation. Furthermore, the BioButton is the only multi-parameter wearable for the Patient Monitoring industry, measuring up to over 1,430 vital signs every day, and allowing practitioners to recognize stable patients who would be eligible for an earlier hospital discharge.
Spacelabs Healthcare announced collaboration with Masimo Corporation to incorporate SET pulse oximetry, NomoLine capnography, rainbow SET Pulse CO-Oximetry, SedLine brain function monitoring, and O3 regional oximetry into several Spacelabs multi-parameter monitors to enable the care team to provide better results.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 5337
Published Date: Oct 12, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Rising cases of chronic diseases and the growing advancements in wearable technology are the major factors driving the growth of the market.
The market size of Multiparameter Patient Monitoring is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024 â€“ 2036.
The major players in the market are Spacelabs Healthcare, Koninklijke Philips N.V., ICU Medical, Inc., GE Healthcare, DrÃ¤gerwerk AG & Co. KGaA, Medtronic, MASIMO CORPORATION, Skanray Technologies, Schiller, Shenzhen Mindray Bio-Medical Electronics Co.
The portable segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.